Craig M Young, MD in Kent, WA - Ophthalmology

Craig M Young, MD is a Ophthalmology physician based in Kent, Washington. Craig M Young is licensed to practice in Washington (license number 0019725) and his current practice location is 24020 132nd Ave Se, Kent, Washington. He can be reached at his office (for appointments etc.) via phone at (253) 631-2929.

NPI number for Craig M Young is 1487647012 and his current mailing address is 24020 132nd Ave Se, Kent, Washington. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1487647012.

Contact Information

	Craig M Young, MD
	24020 132nd Ave Se, Kent, WA 98042-5108
	(253) 631-2929
	(253) 631-2972

Physician's Profile

Full Name	Craig M Young
Gender	Male
Speciality	Ophthalmology
Location	24020 132nd Ave Se, Kent, Washington
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1487647012
Provider Enumeration Date: 08/30/2005
Last Update Date: 10/01/2007

Medical Identifiers

Medical identifiers for Craig M Young such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1487647012	NPI	-	NPPES
1001718	Medicaid	WA

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207W00000X	Ophthalmology	0019725 (Washington)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Craig M Young is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Craig M Young, MD 24020 132nd Ave Se, Kent, WA 98042-5108 Ph: (253) 631-2929	Craig M Young, MD 24020 132nd Ave Se, Kent, WA 98042-5108 Ph: (253) 631-2929

News Archive

ARI-4175 drug may treat colorectal cancer patients with KRAS mutation

When combined with other treatments, the drug cetuximab-which works by slowing or stopping the growth of cancer cells-has been shown to extend survival in certain types of cancer, including metastatic colorectal cancers. Unfortunately, about 40 percent of colorectal cancer patients-specifically those who carry a mutated form of a gene called KRAS-do not respond to the drug. Researchers at Fox Chase Cancer Center in Philadelphia, however, have been working on a way to overcome this resistance to cetuximab by unleashing a second cetuximab driven mechanism using a novel drug called ARI-4175.

Seattle Genetics reports its third-quarter financial results

Seattle Genetics, Inc. today reported financial results for the third quarter and nine months ended September 30, 2009. The company also highlighted recent product development progress.

State highlights: Docs prescribe narcotics too often, CDC chief says; Fla. hospices get close scrutiny; Calif. Medi-Cal provider rate bump delayed

The nation's top public health official on Tuesday sharply criticized the widespread treatment of aches and pains with narcotics, saying that doctors are prescribing such drugs too soon, too often and for too long - putting patients at risk of addiction and overdose. Dr. Tom Frieden, director of the U.S. Centers for Disease Control and Prevention, said that doctors are relying on these powerful drugs to treat chronic pain when physical therapy, exercise and other remedies would be safer and in many cases more effective (Girion and Glover, 7/2).

UNC-Chapel Hill, GSK partner to find cure for HIV/AIDS

The University of North Carolina at Chapel Hill, a leading global public research university with significant expertise in HIV basic and clinical research, and GSK, a global, research-based pharmaceutical and healthcare company with a legacy of success in developing treatments for HIV, today announced the creation of the dedicated HIV Cure center and a jointly owned new company that will focus on discovering a cure for HIV/AIDS.

Ophthalmology Doctors in Kent, WA

Dr. Yicheng Chen, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 321 Ramsay Way Ste 107, Kent, WA 98032 Phone: 206-215-3850 Fax: 206-215-3870
Dr. Amardeep Dhaliwal, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 10803 Se Kent Kangley Rd Ste 103, Kent, WA 98030 Phone: 206-800-3445 Fax: 206-485-2946

Craig M Young, MD - Ophthalmology in Kent, WA